News and Events
Use of a class of pain drugs called gabapentinoids has increased more than three-fold between 2002 and 2015. Gabapentinoids treat epilepsy, burning pain and neuropathic pain associated with diabetes, fibromyalgia, anxiety and restless legs syndrome.
Joel Farley, PhD, has been named the Peters Endowed Chair in Pharmacy Practice Innovation, effective July 1, 2019.
He will provide leadership and oversight of the college’s strategic initiatives based on our strategic plan, and collaboratively foster innovation in all mission areas based on college priorities.
He will lead the Office of Student Services, the Division of Professional and External Relations, and continuing education.
She will provide vision and leadership for professional education, and ensure the curriculum is effectively designed, implemented and delivered.
The awards recognize her exceptional leadership and service to the University of Minnesota and the surrounding community.
Palombi was recognized for her work in the area of substance abuse prevention and intervention, and for her leadership in training people on how to use naloxone.
The award recognizes Blue's outstanding performance and achievement.
The three-year award is given to the most promising faculty who have been newly granted both tenure and promotion to associate professor.
For people who have medical issues like cerebral palsy, multiple sclerosis, and brain and spinal cord injuries, spasticity and involuntary muscle contractions are common. An existing muscle relaxant called baclofen helps to reduce these spasms if taken routinely—but sometimes therapy is abruptly interrupted, which can result in serious adverse effects.
Amy Leslie, Director of Communications